Pulsed Electromagnetic Field (PEMF) Stimulation for Tibia Fractures
A Double Blind Randomised Controlled Trial of Pulsed Electromagnetic Field (PEMF) Stimulation in Acute Tibial Shaft Fractures
1 other identifier
interventional
340
1 country
5
Brief Summary
Fractures of the tibial shaft (diaphysis) are some of the most common long bone fractures. They most frequently occur in males less than 40 years of age. Despite advancements in the surgical management of these fractures, the precarious blood supply and lack of soft-tissue cover of the shaft of the tibia make these fractures vulnerable to non-union and infection. These complications often require multiple procedures, extended time off of work, and can result in ongoing poor mobility. This is reflected in the surgical revision rate that the scientific literature has recorded as being between 20 and 30%. Pulsed electromagnetic field (PEMF) stimulation has been shown to be a safe and effective treatment for non-unions of the tibia. These are fractures in which the bone has failed to unite and the healing process has ceased. The PEMF is delivered via a device such as the EBI Bone Healing System®, which straps onto the limb overlying the fracture. It is lightweight and portable using a rechargeable battery for power. It is compatible with internal and external fixation and may also be worn over a plaster or fibreglass cast. It is usually kept in place for ten hours per day and used for a period of three months or until the fracture unites. In animal models, PEMF stimulation has been demonstrated to improve the time to fracture healing in acute fractures. There have been no demonstrated side effects of the therapy. The study hypothesis is that PEMF stimulation during the first twelve weeks after fracture, in addition to normal surgical care, will increase the union rate for these fractures and thereby significantly reduce the surgical revision rate within the first twelve months following fracture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Aug 2005
Typical duration for phase_2
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 5, 2005
CompletedFirst Posted
Study publicly available on registry
August 8, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedNovember 15, 2005
August 1, 2005
August 5, 2005
November 14, 2005
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Surgical revision rate in the 12 months after fracture
Secondary Outcomes (2)
Fracture union rate at 12, 26 and 52 weeks after fracture
General health score and lower extremity functional score at 12, 26 and 52 weeks after fracture
Interventions
Eligibility Criteria
You may qualify if:
- Acute diaphyseal fracture of the tibia (AO classification 42)
You may not qualify if:
- Pathological fracture secondary to tumours.
- Pregnant patients.
- Patients with permanent pacemakers or defibrillators.
- If the device is unable to be applied by 14 days post fracture.
- Patients who lack the cognitive ability to consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sydney South West Area Health Servicelead
- Biomet Australia Pty Ltd.collaborator
- St George Hospital, Australiacollaborator
- South West Sydney Local Health Districtcollaborator
- University of Wollongongcollaborator
Study Sites (5)
Westmead Hospital
Sydney, New South Wales, 2145, Australia
Liverpool Hospital
Sydney, New South Wales, 2170, Australia
St George Hospital
Sydney, New South Wales, 2217, Australia
Nepean hospital
Sydney, New South Wales, 2570, Australia
Wollongong Hospital
Wollongong, New South Wales, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ian A Harris, MBBS
Sydney South West Area Health Service
- PRINCIPAL INVESTIGATOR
Hamish C Rae, MBBS
Sydney South West Area Health Service
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
August 5, 2005
First Posted
August 8, 2005
Study Start
August 1, 2005
Study Completion
August 1, 2009
Last Updated
November 15, 2005
Record last verified: 2005-08